(CELH) Celsius Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US15118V2079
Stock: Energy Drinks, Hydration Powders, Functional Beverages
Total Rating 53
Risk 37
Buy Signal -0.43
| Risk 5d forecast | |
|---|---|
| Volatility | 63.2% |
| Relative Tail Risk | -13.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.23 |
| Alpha | 57.80 |
| Character TTM | |
|---|---|
| Beta | 1.076 |
| Beta Downside | 0.368 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.86% |
| CAGR/Max DD | 0.20 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 392.5833
Description: CELH Celsius Holdings March 05, 2026
Celsius Holdings, Inc. manufactures and distributes functional energy drinks globally. The companys product portfolio includes CELSIUS branded energy drinks, specialized amino-infused beverages, and powdered hydration products. The functional beverage market is a growing segment within the broader non-alcoholic beverage industry.
Distribution channels are extensive, encompassing direct-to-store delivery, independent distributors, and a wide array of retail outlets including supermarkets, convenience stores, and e-commerce platforms. This multi-channel approach is common for consumer packaged goods companies aiming for broad market penetration.
To further understand CELHs market position, consider exploring its growth metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 108.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -7.24 > 1.0 |
| NWC/Revenue: 29.12% < 20% (prev 70.75%; Δ -41.63% < -1%) |
| CFO/TA 0.07 > 3% & CFO 359.4m > Net Income 108.0m |
| Net Debt (271.1m) to EBITDA (189.9m): 1.43 < 3 |
| Current Ratio: 1.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (237.2m) vs 12m ago 25.65% < -2% |
| Gross Margin: 50.39% > 18% (prev 0.50%; Δ 4988 % > 0.5%) |
| Asset Turnover: 73.05% > 50% (prev 76.72%; Δ -3.68% > 0%) |
| Interest Coverage Ratio: 3.28 > 6 (EBITDA TTM 189.9m / Interest Expense TTM 49.0m) |
Altman Z'' 1.45
| A: 0.14 (Total Current Assets 1.81b - Total Current Liabilities 1.08b) / Total Assets 5.12b |
| B: 0.03 (Retained Earnings 175.9m / Total Assets 5.12b) |
| C: 0.05 (EBIT TTM 160.5m / Avg Total Assets 3.44b) |
| D: 0.08 (Book Value of Equity 179.2m / Total Liabilities 2.18b) |
| Altman-Z'' Score: 1.45 = BB |
Beneish M -0.84
| DSRI: 1.51 (Receivables 755.5m/270.3m, Revenue 2.52b/1.36b) |
| GMI: 1.00 (GM 50.39% / 50.18%) |
| AQI: 3.05 (AQ_t 0.63 / AQ_t-1 0.21) |
| SGI: 1.86 (Revenue 2.52b / 1.36b) |
| TATA: -0.05 (NI 108.0m - CFO 359.4m) / TA 5.12b) |
| Beneish M-Score: -0.84 (Cap -4..+1) = D |
What is the price of CELH shares?
As of March 05, 2026, the stock is trading at USD 45.57 with a total of 9,099,874 shares traded.
Over the past week, the price has changed by -9.96%, over one month by -7.57%, over three months by +6.82% and over the past year by +75.95%.
Over the past week, the price has changed by -9.96%, over one month by -7.57%, over three months by +6.82% and over the past year by +75.95%.
Is CELH a buy, sell or hold?
Celsius Holdings has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy CELH.
- StrongBuy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CELH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.6 | 48.2% |
| Analysts Target Price | 67.6 | 48.2% |
CELH Fundamental Data Overview March 05, 2026
P/E Trailing = 392.5833
P/E Forward = 30.8642
P/S = 4.8282
P/B = 10.5526
P/EG = 0.7499
Revenue TTM = 2.52b USD
EBIT TTM = 160.5m USD
EBITDA TTM = 189.9m USD
Long Term Debt = 861.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 669.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 271.1m USD (from netDebt column, last quarter)
Enterprise Value = 12.42b USD (12.14b + Debt 669.9m - CCE 398.9m)
Interest Coverage Ratio = 3.28 (Ebit TTM 160.5m / Interest Expense TTM 49.0m)
EV/FCF = 38.39x (Enterprise Value 12.42b / FCF TTM 323.4m)
FCF Yield = 2.60% (FCF TTM 323.4m / Enterprise Value 12.42b)
FCF Margin = 12.86% (FCF TTM 323.4m / Revenue TTM 2.52b)
Net Margin = 4.29% (Net Income TTM 108.0m / Revenue TTM 2.52b)
Gross Margin = 50.39% ((Revenue TTM 2.52b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 47.37% (prev 51.34%)
Tobins Q-Ratio = 2.43 (Enterprise Value 12.42b / Total Assets 5.12b)
Interest Expense / Debt = 1.89% (Interest Expense 12.7m / Debt 669.9m)
Taxrate = 13.62% (17.0m / 125.0m)
NOPAT = 138.6m (EBIT 160.5m * (1 - 13.62%))
Current Ratio = 1.68 (Total Current Assets 1.81b / Total Current Liabilities 1.08b)
Debt / Equity = 0.23 (Debt 669.9m / totalStockholderEquity, last quarter 2.94b)
Debt / EBITDA = 1.43 (Net Debt 271.1m / EBITDA 189.9m)
Debt / FCF = 0.84 (Net Debt 271.1m / FCF TTM 323.4m)
Total Stockholder Equity = 2.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 108.0m / Total Assets 5.12b)
RoE = 4.66% (Net Income TTM 108.0m / Total Stockholder Equity 2.32b)
RoCE = 5.05% (EBIT 160.5m / Capital Employed (Equity 2.32b + L.T.Debt 861.5m))
RoIC = 8.97% (NOPAT 138.6m / Invested Capital 1.55b)
WACC = 9.45% (E(12.14b)/V(12.81b) * Re(9.88%) + D(669.9m)/V(12.81b) * Rd(1.89%) * (1-Tc(0.14)))
Discount Rate = 9.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF] Terminal Value 76.70% ; FCFF base≈289.8m ; Y1≈357.5m ; Y5≈608.9m
[DCF] Fair Price = 29.76 (EV 7.94b - Net Debt 271.1m = Equity 7.67b / Shares 257.8m; r=9.45% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 35.02 | EPS CAGR: 34.61% | SUE: 0.93 | # QB: 2
Revenue Correlation: 89.32 | Revenue CAGR: 56.86% | SUE: 2.12 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=-0.003 | Chg30d=-0.008 | Revisions Net=+2 | Analysts=15
EPS current Year (2026-12-31): EPS=1.62 | Chg7d=+0.068 | Chg30d=+0.060 | Revisions Net=+5 | Growth EPS=+20.9% | Growth Revenue=+34.6%
EPS next Year (2027-12-31): EPS=2.04 | Chg7d=+0.167 | Chg30d=+0.168 | Revisions Net=+7 | Growth EPS=+26.0% | Growth Revenue=+10.1%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 9.9% - Earnings Yield 0.3%)
[Growth] Growth Spread = +15.0% (Analyst 24.7% - Implied 9.6%)
P/E Forward = 30.8642
P/S = 4.8282
P/B = 10.5526
P/EG = 0.7499
Revenue TTM = 2.52b USD
EBIT TTM = 160.5m USD
EBITDA TTM = 189.9m USD
Long Term Debt = 861.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 669.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 271.1m USD (from netDebt column, last quarter)
Enterprise Value = 12.42b USD (12.14b + Debt 669.9m - CCE 398.9m)
Interest Coverage Ratio = 3.28 (Ebit TTM 160.5m / Interest Expense TTM 49.0m)
EV/FCF = 38.39x (Enterprise Value 12.42b / FCF TTM 323.4m)
FCF Yield = 2.60% (FCF TTM 323.4m / Enterprise Value 12.42b)
FCF Margin = 12.86% (FCF TTM 323.4m / Revenue TTM 2.52b)
Net Margin = 4.29% (Net Income TTM 108.0m / Revenue TTM 2.52b)
Gross Margin = 50.39% ((Revenue TTM 2.52b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 47.37% (prev 51.34%)
Tobins Q-Ratio = 2.43 (Enterprise Value 12.42b / Total Assets 5.12b)
Interest Expense / Debt = 1.89% (Interest Expense 12.7m / Debt 669.9m)
Taxrate = 13.62% (17.0m / 125.0m)
NOPAT = 138.6m (EBIT 160.5m * (1 - 13.62%))
Current Ratio = 1.68 (Total Current Assets 1.81b / Total Current Liabilities 1.08b)
Debt / Equity = 0.23 (Debt 669.9m / totalStockholderEquity, last quarter 2.94b)
Debt / EBITDA = 1.43 (Net Debt 271.1m / EBITDA 189.9m)
Debt / FCF = 0.84 (Net Debt 271.1m / FCF TTM 323.4m)
Total Stockholder Equity = 2.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 108.0m / Total Assets 5.12b)
RoE = 4.66% (Net Income TTM 108.0m / Total Stockholder Equity 2.32b)
RoCE = 5.05% (EBIT 160.5m / Capital Employed (Equity 2.32b + L.T.Debt 861.5m))
RoIC = 8.97% (NOPAT 138.6m / Invested Capital 1.55b)
WACC = 9.45% (E(12.14b)/V(12.81b) * Re(9.88%) + D(669.9m)/V(12.81b) * Rd(1.89%) * (1-Tc(0.14)))
Discount Rate = 9.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF] Terminal Value 76.70% ; FCFF base≈289.8m ; Y1≈357.5m ; Y5≈608.9m
[DCF] Fair Price = 29.76 (EV 7.94b - Net Debt 271.1m = Equity 7.67b / Shares 257.8m; r=9.45% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 35.02 | EPS CAGR: 34.61% | SUE: 0.93 | # QB: 2
Revenue Correlation: 89.32 | Revenue CAGR: 56.86% | SUE: 2.12 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=-0.003 | Chg30d=-0.008 | Revisions Net=+2 | Analysts=15
EPS current Year (2026-12-31): EPS=1.62 | Chg7d=+0.068 | Chg30d=+0.060 | Revisions Net=+5 | Growth EPS=+20.9% | Growth Revenue=+34.6%
EPS next Year (2027-12-31): EPS=2.04 | Chg7d=+0.167 | Chg30d=+0.168 | Revisions Net=+7 | Growth EPS=+26.0% | Growth Revenue=+10.1%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 9.9% - Earnings Yield 0.3%)
[Growth] Growth Spread = +15.0% (Analyst 24.7% - Implied 9.6%)